Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA rule allowing gay and bisexual men to donate blood indicates positive change In 2023, the U.S. Food and Drug Administration updated its guidelines to allow gay and bisexual men to donate blood, focusing ... READ MORE >
Life sciences
5 things to know in life sciences: Week of June 10, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Embracing inclusivity: How biopharmas connect with LGBTQ+ employees Biopharma companies are increasingly creating inclusive workplaces through employee resource groups (ERGs), with 75% of employers now having ... READ MORE >
5 things to know in life sciences: Week of June 3, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biopharma research productivity increases Recent advancements in artificial intelligence are significantly enhancing research and development productivity by streamlining drug discovery processes, leading to ... READ MORE >
5 things to know in life sciences: Week of May 27, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA issues draft guidance on platform technology designation The Food and Drug Administration has released a draft guidance aimed at providing a framework for the designation of platform technologies, which ... READ MORE >
5 things to know in life sciences: Week of May 20, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. New collaboration explores AI-based digital pathology Microsoft is collaborating with researchers from the University of Washington as well as Providence health network to develop a new artificial ... READ MORE >
5 things to know in life sciences: Week of May 13, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA approves new self-collection approach to cervical cancer screening According to the Washington Post, the Food and Drug Administration has approved a newly developed screening test for cervical cancer that ... READ MORE >
New tariffs on medical equipment could strain health care and life sciences supply chains
Health care and life sciences organizations’ operations could be affected by recent tariff increases on Chinese medical equipment imports as part of a broader economic regime shift to embrace industrial policy. The Biden administration, in an effort to address what it calls unfair trade policies and ... READ MORE >
5 things to know in life sciences: Week of May 6, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biopharma industry challenges Biosecure Act BioCentury reports that the biopharma industry is actively lobbying for changes to the Biosecure Act aiming to modify legislative measures that could impact U.S. ... READ MORE >
5 things to know in life sciences: Week of April 29, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA releases final rule on laboratory developed tests On April 29, the U.S. Food and Drug Administration issued a final rule regarding regulation of laboratory developed tests, following a proposed rule in ... READ MORE >
Key takeaways for life sciences on laboratory developed tests final rule
The U.S. Food and Drug Administration released a final rule yesterday regarding the regulation of laboratory developed tests, also known as LDTs. This final rule follows a proposed rule that was released last fall. While the final rule closely follows the proposed rule released late last year, there are ... READ MORE >